The relationship between changes in peritoneal permeability with CA-125 and HIF-1α

Area of Science:

• Nephrology
• Biomarker Discovery
• Peritoneal Dialysis

Background:

• Peritoneal fibrosis (PF) is a serious complication of long-term peritoneal dialysis (PD), leading to ultrafiltration failure.
• Factors like high glucose, toxins, and peritonitis can damage the peritoneal membrane, causing inflammation and PF.
• CA-125 is a biomarker for mesothelial cell count, while Hypoxia-inducible factor 1-alpha (HIF-1α) is implicated in PF but its association with structural changes is unclear.

Purpose of the Study:

• To investigate the relationship between HIF-1α and CA-125 levels and changes in peritoneal membrane permeability in PD patients.
• To explore the potential of HIF-1α and CA-125 as biomarkers for monitoring peritoneal adequacy and structural changes during PD.

Main Methods:

• Studied 45 PD patients, categorizing them by peritoneal permeability changes (stable, increased, decreased).
• Measured serum HIF-1α and peritoneal fluid CA-125 levels.
• Analyzed the correlation between peritoneal variability, HIF-1α, and CA-125 over time.

Main Results:

• Serum HIF-1α levels were significantly higher in patients with high-to-low permeability changes compared to stable or low-to-high changes.
• Peritoneal fluid CA-125 levels significantly decreased in patients with high-to-low permeability changes.
• HIF-1α levels increased as peritoneal permeability changed, while CA-125 levels decreased.

Conclusions:

• Peritoneal membrane structural changes can be effectively monitored using biomarkers.
• CA-125 and HIF-1α levels serve as valuable indicators for guiding changes in the peritoneal membrane during PD.
• These biomarkers can enhance the monitoring process for patients undergoing peritoneal dialysis.